Results 81 to 90 of about 4,713 (170)

Invariant Natural Killer T Cells in Cancer Immunotherapy: Lipid-Based Modulation, Nanotechnology, and Translational Advances. [PDF]

Int J Mol Sci
Aloliqi AA, Alnuqaydan AM, Alshebremi M, Khan A, Khan MA.   +4 more
europepmc   +1 more source

Activation of Invariant Natural Killer T Cells Enhances Ischemia-Reperfusion Injury in Steatotic Mouse Livers. [PDF]

In Vivo
Kuroda YU, Ito Y, Nishizawa N, Tanabe M, Goto T, Yamashita A, Hosono K, Satoh M, Kumamoto Y, Hiki N, Amano H.   +10 more
europepmc   +1 more source

PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. [PDF]

J Immunother Cancer
Burks J, Tiwary S, Stevens DM, Skoczen SL, Kularatne RN, Stern ST, Berzofsky JA.   +6 more
europepmc   +1 more source

Synthesis of Spin-Labeled α-/β-Galactosylceramides and Glucosylceramides as Electron Paramagnetic Probes. [PDF]

J Org Chem
Rohokale R, Mane R, Malet L, Dessain S, Guo Z.   +4 more
europepmc   +1 more source

Does Amyotrophic Lateral Sclerosis (ALS) Have Metabolic Causes from Human Evolution? [PDF]

Cells
Spedding M.
europepmc   +1 more source

Maternal and cord blood lipidomics as predictors of autism spectrum disorders: A systematic review. [PDF]

Metabol Open
Sarantaki A, Ghanchi A, Vermeulen J, Barbouni A, Charvalos E, Sousamli A, Anagnostopoulos DK.   +6 more
europepmc   +1 more source

Bioactivities and Anti-Cancer Activities of NKT-Stimulatory Phenyl-Glycolipid Formulated with a PEGylated Lipid Nanocarrier. [PDF]

Drug Des Devel Ther
Hung JT, Chiou SP, Tang YH, Huang JR, Lo FY, Yu AL.   +5 more
europepmc   +1 more source

State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues. [PDF]

Front Immunol
Praveena T, Le Nours J.
europepmc   +1 more source

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]

PLoS One
Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, Inaba Y, Fujiwara T, Hattori Y, Fukazawa T, Aoki T, Koseki H, Hanaoka H, Hanazawa T, Motohashi S.   +12 more
europepmc   +1 more source

Don't Be Surprised When These Surprise You: Some Infrequently Studied Sphingoid Bases, Metabolites, and Factors That Should Be Kept in Mind During Sphingolipidomic Studies. [PDF]

Int J Mol Sci
Merrill AH.
europepmc   +1 more source